Literature DB >> 3044184

The seed stock concept and quality control for cell lines.

R J Hay1.   

Abstract

Procedures for the characterization of cell culture lines are reviewed. It is recommended that seed stocks be developed and that major quality-control efforts be applied first to those holdings, with essential tests repeated on cultures from working or distribution stocks prepared subsequently. Steps are taken throughout to ensure absence of microbial contaminants. Mycoplasma are especially troublesome. Investigators need also to be aware of potential endogenous viruses which may be hazardous or interfere with interpretation of results. Cell line species and absolute identities are established by fluorescent antibody staining, by determination of isoenzyme profiles, and by cytogenetic analyses. Additional characterizations will vary with cell type but may include tests for specific products, cytoskeletal proteins, tissue specific antigens, or immunoglobulins. Credentials of lines added to a collection plus representative cultures can be returned to the originators for concurrence before distribution. Advisory committees may be established as circumstance dictates to provide additional expertise regarding quality control for the specific collection being developed.

Entities:  

Mesh:

Year:  1988        PMID: 3044184     DOI: 10.1016/0003-2697(88)90480-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  16 in total

1.  DNA fingerprinting--a valuable new technique for the characterisation of cell lines.

Authors:  G Stacey; B Bolton; A Doyle; B Griffiths
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Cell culture systems and in vitro toxicity testing. Technical report no. 4 of the Johns Hopkins Center for Alternatives to Animal Testing (CAAT): technical workshop of June 13-15, 1990.

Authors: 
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes.

Authors:  G Bernhardt; R Gust; H Reile; H D vom Orde; R Müller; C Keller; T Spruss; H Schönenberger; T Burgemeister; A Mannschreck
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Rapid authentication of animal cell lines using pyrolysis mass spectrometry and auto-associative artificial neural networks.

Authors:  R Goodacre; D J Rischert; P M Evans; D B Kell
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

5.  Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.

Authors:  G Bernhardt; H Reile; H Birnböck; T Spruss; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 6.  Biobanking.

Authors:  John G Day; Glyn N Stacey
Journal:  Mol Biotechnol       Date:  2008-09-09       Impact factor: 2.695

7.  Sensitivity of isoenzyme analysis for the detection of interspecies cell line cross-contamination.

Authors:  R W Nims; A P Shoemaker; M A Bauernschub; L J Rec; J W Harbell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

8.  Tumor-inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. V. Synthesis and evaluation of enantiomeric [1,2-bis-(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes.

Authors:  H D vom Orde; H Reile; R Müller; R Gust; G Bernhardt; T Spruss; H Schönenberger; T Burgemeister; A Mannschreck
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

9.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line.

Authors:  G Bernhardt; R Gust; H Reile; H D vom Orde; R Müller; C Keller; T Spruss; H Schönenberger; T Burgemeister; A Mannschreck
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.